Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1994 1
2000 1
2003 1
2004 1
2005 1
2006 3
2008 2
2009 6
2010 5
2011 5
2012 10
2013 9
2014 6
2015 8
2016 10
2017 12
2018 11
2019 13
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32868302

101 results
Results by year
Filters applied: . Clear all
Page 1
Emerging blood-based biomarkers for Alzheimer disease.
Bekris LM, Leverenz JB. Bekris LM, et al. Cleve Clin J Med. 2020 Aug 31;87(9):537-539. doi: 10.3949/ccjm.87a.20133. Cleve Clin J Med. 2020. PMID: 32868302 Free article. No abstract available.
Emerging ocular biomarkers of Alzheimer disease.
van Wijngaarden P, Hadoux X, Alwan M, Keel S, Dirani M. van Wijngaarden P, et al. Clin Exp Ophthalmol. 2017 Jan;45(1):54-61. doi: 10.1111/ceo.12872. Epub 2016 Dec 19. Clin Exp Ophthalmol. 2017. PMID: 28147442 Review.
The role of biomarkers in clinical trials for Alzheimer disease.
Thal LJ, Kantarci K, Reiman EM, Klunk WE, Weiner MW, Zetterberg H, Galasko D, Praticò D, Griffin S, Schenk D, Siemers E. Thal LJ, et al. Alzheimer Dis Assoc Disord. 2006 Jan-Mar;20(1):6-15. doi: 10.1097/01.wad.0000191420.61260.a8. Alzheimer Dis Assoc Disord. 2006. PMID: 16493230 Free PMC article. Review.
Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology.
Gordon BA, Blazey T, Su Y, Fagan AM, Holtzman DM, Morris JC, Benzinger TL. Gordon BA, et al. JAMA Neurol. 2016 Oct 1;73(10):1192-1200. doi: 10.1001/jamaneurol.2016.2642. JAMA Neurol. 2016. PMID: 27548756 Free PMC article.
Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.
Lönneborg A. Lönneborg A. Mol Diagn Ther. 2008;12(5):307-20. doi: 10.1007/BF03256296. Mol Diagn Ther. 2008. PMID: 18803429 Review.
Emerging biomarkers in cognition.
Wicklund M, Petersen RC. Wicklund M, et al. Clin Geriatr Med. 2013 Nov;29(4):809-28. doi: 10.1016/j.cger.2013.07.006. Clin Geriatr Med. 2013. PMID: 24094298 Free PMC article. Review.
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Olsson B, Lautner R, Andreasson U, Öhrfelt A, Portelius E, Bjerke M, Hölttä M, Rosén C, Olsson C, Strobel G, Wu E, Dakin K, Petzold M, Blennow K, Zetterberg H. Olsson B, et al. Lancet Neurol. 2016 Jun;15(7):673-684. doi: 10.1016/S1474-4422(16)00070-3. Epub 2016 Apr 8. Lancet Neurol. 2016. PMID: 27068280 Review.
Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
Schreiber S, Schreiber F, Lockhart SN, Horng A, Bejanin A, Landau SM, Jagust WJ; Alzheimer’s Disease Neuroimaging Initiative. Schreiber S, et al. JAMA Neurol. 2017 Jun 1;74(6):650-659. doi: 10.1001/jamaneurol.2016.5349. JAMA Neurol. 2017. PMID: 28319241 Free PMC article.
A test of lens opacity as an indicator of preclinical Alzheimer Disease.
Bei L, Shui YB, Bai F, Nelson SK, Van Stavern GP, Beebe DC. Bei L, et al. Exp Eye Res. 2015 Nov;140:117-123. doi: 10.1016/j.exer.2015.03.010. Epub 2015 Mar 13. Exp Eye Res. 2015. PMID: 25773986 Free PMC article.
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.
Blennow K, Hampel H, Weiner M, Zetterberg H. Blennow K, et al. Nat Rev Neurol. 2010 Mar;6(3):131-44. doi: 10.1038/nrneurol.2010.4. Epub 2010 Feb 16. Nat Rev Neurol. 2010. PMID: 20157306 Review.
101 results
Jump to page
Feedback